A 72-year-old client on chronic warfarin (target INR 2.0–3.0… | MyMerci
Adverse Effects/Contraindications/Interactions PA
Question

A 72-year-old client on chronic warfarin (target INR 2.0–3.0) is brought to the ED after a fall down the stairs. The client has a large scalp laceration, decreased level of consciousness, and a head CT showing acute intracranial hemorrhage. Vital signs: BP 168/96, HR 102, RR 22. Stat INR is 3.8. Which set of orders does the nurse anticipate as the priority for urgent reversal?

Explanation
Warfarin-related life-threatening hemorrhage — emergency reversal
Intracranial hemorrhage on warfarin is a true emergency. INR alone is misleading — even a value within target range can accompany life-threatening bleeding when the patient has anticoagulant on board. Standard guideline-based reversal:

(1) Hold all anticoagulants/antiplatelets immediately.
(2) 4-factor PCC (Kcentra) is preferred over FFP because it acts within minutes, requires small volume (~100 mL), and replaces factors II, VII, IX, X plus protein C and S. Dose is INR-guided per weight (e.g., 25 IU/kg for INR 2-3.9, 35 IU/kg for INR 4-6, 50 IU/kg for INR >6, max 5000 IU). FFP is used only if PCC is unavailable (slower onset, large volume, fluid overload risk).
(3) Slow IV vitamin K 5-10 mg co-administered to provide sustained reversal. Vitamin K corrects more slowly (12-24 h) but prevents INR rebound after PCC wears off. Push too fast risks anaphylactoid reaction — give over ≥30 minutes diluted.
(4) Continuous monitoring: ECG, BP, repeat neuro exam, and recheck INR after PCC.
(5) Concurrent supportive care: neurosurgery consult, blood pressure control, head-of-bed positioning per neuro guidance, seizure precautions, definitive surgical management as indicated.

Other choices:
• Option 2 (hold + low-dose oral vitamin K + 24-h recheck) is appropriate for asymptomatic supratherapeutic INR, NOT life-threatening hemorrhage.
• Option 4 (continue warfarin, observe) is dangerous — bleeding will progress.
• Option 3 (protamine sulfate) reverses HEPARIN, not warfarin. Confusing the two is a high-frequency NCLEX trap.

In-depth explanation

Clinical reasoning summary
Warfarin-related life-threatening hemorrhage — emergency reversal
Intracranial hemorrhage on warfarin is a true emergency. INR alone is misleading — even a value within target range can accompany life-threatening bleeding when the patient has anticoagulant on board. Standard guideline-based reversal:

(1) Hold all anticoagulants/antiplatelets immediately.
(2) 4-factor PCC (Kcentra) is preferred over FFP because it acts within minutes, requires small volume (~100 mL), and replaces factors II, VII, IX, X plus protein C and S. Dose is INR-guided per weight (e.g., 25 IU/kg for INR 2-3.9, 35 IU/kg for INR 4-6, 50 IU/kg for INR >6, max 5000 IU). FFP is used only if PCC is unavailable (slower onset, large volume, fluid overload risk).
(3) Slow IV vitamin K 5-10 mg co-administered to provide sustained reversal. Vitamin K corrects more slowly (12-24 h) but prevents INR rebound after PCC wears off. Push too fast risks anaphylactoid reaction — give over ≥30 minutes diluted.
(4) Continuous monitoring: ECG, BP, repeat neuro exam, and recheck INR after PCC.
(5) Concurrent supportive care: neurosurgery consult, blood pressure control, head-of-bed positioning per neuro guidance, seizure precautions, definitive surgical management as indicated.

Other choices:
• Option 1 (hold + low-dose oral vitamin K + 24-h recheck) is appropriate for asymptomatic supratherapeutic INR, NOT life-threatening hemorrhage.
• Option 2 (continue warfarin, observe) is dangerous — bleeding will progress.
• Option 4 (protamine sulfate) reverses HEPARIN, not warfarin. Confusing the two is a high-frequency NCLEX trap.
Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free
Read in another language: English한국어日本語繁體中文Tiếng Việt

For study reference only. Always follow current clinical guidelines and your institution’s protocols.